Avellino Labs
Gene is the Founder, Chairman of the board of directors, and visionary behind the Avellino Labs network of companies. A serial entrepreneur, he started Avellino Labs in 2008 in South Korea and brings more than 20 years of experience leading pharmaceutical, healthcare, and genetic diagnostics teams. In 2013, Gene relocated to Silicon Valley to support Avellino Labs’ transition to a US-based global company. Gene is also the lead investor and author of most of the patents in Avellino’s IP portfolio. In 2015, the World Economic Forum recognized Avellino Labs as a Technology Pioneer and honored Gene with membership on its Global Precision Medicine Council. Gene was awarded the Ellis Island Medal of Honor for his pioneering work in gene therapy and molecular diagnostics at a ceremony on Ellis Island on May 11, 2019.
This person is not in the org chart
This person is not in any offices
Avellino Labs
Avellino Labs is a global leader in gene therapy and molecular diagnostics, and the pioneer in personalized medicine for eye care. Avellino Labs is pioneering CRISPR gene editing to manage and potentially cure inherited diseases. Avellino Labs continues to expand its diagnostics capabilities, building on the success of the world's first DNA test to confirm the presence of genetic indicators that are positively associated with corneal dystrophies, providing life-changing information for patient treatment decisions and follow up care. Avellino Labs is headquartered in Silicon Valley, California, with operations in Korea, Japan, China and the UK.